Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
AMEX
OS Therapies Incorporated (OSTX)
OS Therapies Incorporated (OSTX) News

OSTX

OS Therapies (OSTX)

OS Therapies Incorporated

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:OSTX

1

Date	Time	Source	Headline	Symbol	Company
09/13/2024	8:09AM	Business Wire	OS Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic Candidates	AMEX:OSTX	OS Therapies Incorporated
09/05/2024	8:22AM	Business Wire	OS Therapies to Present at H.C. Wainright 26th Annual Global Investment Conference	AMEX:OSTX	OS Therapies Incorporated
08/29/2024	7:53AM	Business Wire	OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Receives Last Treatment Dose	AMEX:OSTX	OS Therapies Incorporated
08/22/2024	8:00AM	Business Wire	OS Therapies Appoints Borys Shor, PhD to ADC Advisory Board	AMEX:OSTX	OS Therapies Incorporated
08/22/2024	6:00AM	Business Wire	OS Therapies Clarifies CUSIP of Common Stock	AMEX:OSTX	OS Therapies Incorporated
08/19/2024	8:30AM	Business Wire	OS Therapies Accepted Into Johnson & Johnson Innovation - JLABS	AMEX:OSTX	OS Therapies Incorporated
08/02/2024	8:55AM	Business Wire	OS Therapies Forms Osteosarcoma Patient Advocacy Advisory Board	AMEX:OSTX	OS Therapies Incorporated
08/01/2024	9:19AM	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:OSTX	OS Therapies Incorporated
08/01/2024	9:16AM	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:OSTX	OS Therapies Incorporated
08/01/2024	9:11AM	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:OSTX	OS Therapies Incorporated
08/01/2024	9:10AM	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:OSTX	OS Therapies Incorporated
08/01/2024	9:08AM	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:OSTX	OS Therapies Incorporated
08/01/2024	12:15AM	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	AMEX:OSTX	OS Therapies Incorporated
07/31/2024	6:21PM	Business Wire	OS Therapies Announces Pricing of its Initial Public Offering on NYSE American - Company to Trade under Symbol “OSTX”	AMEX:OSTX	OS Therapies Incorporated
07/30/2024	2:41PM	Edgar (US Regulatory)	Form CERT - Certification by an exchange approving securities for listing	AMEX:OSTX	OS Therapies Incorporated
07/30/2024	2:29PM	Edgar (US Regulatory)	Form 8-A12B - Registration of securities [Section 12(b)]	AMEX:OSTX	OS Therapies Incorporated
07/24/2024	10:48AM	Business Wire	OS Therapies Announces Positive Safety Data from Phase 1 Clinical Trial of OST-HER2 in HER2-Expressing Breast Cancer and in Preclinical Efficacy in Models of Breast Cancer	AMEX:OSTX	OS Therapies Incorporated
06/03/2024	12:44PM	Business Wire	OS Therapies Announces Positive Clinical Update from Ongoing Phase 2b Clinical Trial in Resected, Recurrent Osteosarcoma	AMEX:OSTX	OS Therapies Incorporated

Showing the most relevant articles for your search:AMEX:OSTX

1

First Mining Gold (QX)

Lehman Brothers Financial (CE)

NioCorp Developments

Anavex Life Sciences

Kraig Biocraft Laborator... (QB)

Asia Broadband (PK)

Intergrated Cannabis Sol... (PK)

Rennova Health (CE)

Digital Brand Media and ... (PK)

Moon Equity (PK)

Elite Pharmaceuticals (QB)

Bioelectronics (PK)

Northwest Biotherapeutics (QB)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions